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Background: Our interests lie in determining the genes and genetic pathways that are important for establishing
and maintaining maternal-fetal interactions during pregnancy. Mutation analysis targeted to a 34 Mb domain
flanked by Trp53 and Wnt3 demonstrates that this region of mouse chromosome 11 contains a large number of
essential genes. Two mutant alleles (l11Jus1 and l11Jus4), which fall into the same complementation group, survive
through implantation but fail prior to gastrulation.
Results: Through a positional cloning strategy, we discovered that these homozygous mutant alleles contain
non-conservative missense mutations in the Notchless homolog 1 (Drosophila) (Nle1) gene. NLE1 is a member of the
large WD40-repeat protein family, and is thought to signal via the canonical NOTCH pathway in vertebrates.
However, the phenotype of the Nle1 mutant mice is much more severe than single Notch receptor mutations or
even in animals in which NOTCH signaling is blocked. To test the hypothesis that NLE1 functions in multiple
signaling pathways during pre-implantation development, we examined expression of multiple Notch downstream
target genes, as well as select members of the Wnt pathway in wild-type and mutant embryos. We did not detect
altered expression of any primary members of the Notch pathway or in Notch downstream target genes. However,
our data reveal that Cdkn1a, a NOTCH target, was upregulated in Nle1 mutants, while several members of the Wnt
pathway are downregulated. In addition, we found that Nle1 mutant embryos undergo caspase-mediated apoptosis
as hatched blastocysts, but not as morulae or blastocysts.
Conclusions: Taken together, these results uncover potential novel functions for NLE1 in the WNT and CDKN1A
pathways during embryonic development in mammals.
Keywords: Notchless homolog 1 (Drosophila), Notch, Wnt, Cdkn1a, ENU mutagenesis, Pre-implantation development,
Mouse, Embryonic lethal* Correspondence: alossie@purdue.edu
1Department of Animal Sciences, Purdue University, West Lafayette, IN 47907,
USA
2PULSe Interdisciplinary Life Science Program, Purdue University, West
Lafayette, IN, USA
Full list of author information is available at the end of the article
© 2012 Lossie et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Lossie et al. BMC Genetics 2012, 13:106 Page 2 of 16
http://www.biomedcentral.com/1471-2156/13/106Background
Mouse chromosome (Mmu Chr) 11 shares significant
synteny conservation with regions of six different human
(Hsa) chromosomes: 22, 7, 2, 5, 1 and 17 [1]. The largest
domain of synteny conservation between mouse and
human occurs on distal Mmu 11, which is entirely
syntenic with Hsa 17 [2]. The gene-rich domain flanked
by Trp53 and Wnt3 in this region of synteny conservation
contains 2545 gene structures, including 1597 predicted
protein-coding genes, 450 processed RNAs and 498
pseudogenes [1].
A large-scale, phenotype-driven ENU (N-ethyl-N-
nitrosourea) mutagenesis screen targeted to this 34 Mb re-
gion ofMmu 11 demonstrated the wide functional diversity
of this linkage group [2-4]. Functional analysis of 785 total
pedigrees from this ENU mutagenesis screen resulted in
the discovery of a variety of mutant phenotypes, including
infertility, craniofacial abnormalities, neurological defects
and lethality [4]. Subsequent studies detailed the embryonic
lethal phenotypes of 45 mutant lines that fell into 40 com-
plementation groups [3,4]. Resequencing efforts led to the
identification of causative or putatively causative lesions in
31 genes in 17 lethal lines [1].
Although many mutations were identified in the
sequencing study, the lesions in the l11Jus1 and l11Jus4
complementation group have yet to be identified. These
two alleles survive through implantation but arrest prior
to embryonic day (E) 6.5 [3,4]. Our interests lie in deter-
mining the genes and genetic pathways that are important
for establishing and maintaining maternal-fetal inter-
actions during pregnancy. Since these two mutants fail
during this critical window, we undertook a positional
cloning strategy to identify the causative mutations in this
complementation group. Here, we present evidence that
both mutant alleles have non-conservative missense muta-
tions in the Notchless homolog 1 (Drosophila) gene, Nle1.
Moreover, targeted disruption of Nle1 in mice [5] results
in an embryonic lethal phenotype that is remarkably simi-
lar to l11Jus1 and l11Jus4, providing further supporting
evidence that Nle1 is disrupted in both mutant alleles.
NLE1, which is a member of the WD40 repeat protein
family, was first identified as a suppressor of the
notchoid phenotype in Drosophila [6], and has been
implicated in both positive and negative regulation of
NOTCH signaling, depending upon developmental stage
and species [5,6]. Studies in Drosophila and Xenopus
demonstrate that NLE1 signals via the canonical
NOTCH pathway [5,6]. In invertebrates and lower
vertebrates, the NOTCH pathway is critical for directing
cell fate prior to gastrulation, and also plays important,
but varied roles in germ layer boundary formation. At
the 4-cell stage in C. elegans, NOTCH signaling dictates
an ectodermal cell fate in ABp daughter cells by repres-
sing expression of TBX-37 and TBX-38 [7]. In seaurchins, the NOTCH pathway impacts the development
and differentiation of the secondary mesenchymal cells,
which are fated to produce mesodermal cells [8,9]. In
contrast, in X. laevis, induction of NOTCH signaling
leads to an increase in endoderm-specific and a decrease
in mesoderm-specific markers, while suppression of
NOTCH signaling has the opposite consequence [10].
The role of NOTCH signaling during the earliest stages
of mammalian development is much less clear. Several lines
of evidence demonstrate that NOTCH signaling is dispen-
sable for gastrulation in mice. Single gene and compound
knockout studies of the Notch receptors and ligands results
in either viable animals or embryonic lethality at mid-
gestation [11-21]. Similarly, deletion of genes that block
NOTCH signaling, such as Pofut1 and members of the
γ-secretase complex, leads to embryonic failure after gas-
trulation and midline formation. POFUT1 adds O-fucose
molecules to NOTCH receptors prior to their translocation
to the cell surface, while Presenilin 1 and 2 are members of
the γ-secretase complex [22,23]. This complex cleaves
NOTCH at the cell membrane, releasing the NOTCH
intracellular domain (NICD) into the cytoplasm. The NICD
translocates to the nucleus and binds to RBPJ, thereby
modulating transcription of downstream target genes.
Deletion of Pofut1, which effectively blocks NOTCH
signaling through inhibition of post-translational modifi-
cations to NOTCH receptors [24], leads to embryonic
lethality at E9.5 [25,26]. Targeted disruption of Presenilin
2 in a Presenilin 1 null background leads to embryonic
lethality at E9.5. Compound mutants exhibit cardiac,
somite and neurological phenotypes [27]. Finally, deletion
of the co-repressor, Rbpj, causes somitogenesis defects,
placental abnormalities and marked growth delay [28,29].
These studies demonstrate that unlike lower vertebrates
and invertebrates, and despite the fact that Notch recep-
tors and ligands are expressed prior to and during gastru-
lation [30], NOTCH signaling is dispensable prior to
gastrulation in mice.
Since Nle1l11Jus1 and Nle1l11Jus4 mutants have more
severe phenotypes than mutations that disrupt NOTCH
signaling in mice, we hypothesized that NLE1 interacts
with NOTCH and other signaling pathways during pre-
implantation development. To address this hypothesis, we
conducted targeted gene expression studies in homozy-
gous mutant embryos. Surprisingly, and in contrast to
studies in Xenopus and Drosophila, our data indicate that
canonical NOTCH signaling is not disrupted in Nle1
mutant embryos; instead, we discovered that Cdkn1a was
upregulated, while several members of the Wnt cascade
were downregulated in homozygous mutant embryos.
These results highlight the differences in NOTCH
signaling between mammals (where canonical NOTCH
signaling is dispensable for gastrulation) and other species
(where NOTCH signaling is required for gastrulation)
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development that depend upon other signal transduction
cascades.
Methods
Mouse strains, meiotic mapping and generation of
mutant embryos
The l11Jus1 and l11Jus4 mutants were induced by ENU
mutagenesis on a C57BL/6J background [3,4], and
maintained in trans using a balancer chromosome
(In(11Trp53;11Wnt3)8Brd) harboring a 34 Mb inversion
between Trp53 and Wnt3 that expresses the agouti pro-
tein under the Keratin 14 promoter (Figure 1A) [31]. The
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Figure 1 Positional Cloning of l11Jus1 and l11Jus4. A. Exclusion Mappin
Green line with the double arrow: 34 Mb inversion (In(11Trp53;11Wnt3)8Brd
which confers a curly coat. Plus sign: wild type locus. All animals carrying t
phenotypes and crossover events are depicted in the F2 generation. B. Ma
box represents a locus within Mmu 11. Yellow boxes are homozygous 129S
SvEvTac and C57BL/6J genotypes; while blue boxes indicate homozygous C
critical region. C. Physical map of the non-recombinant interval. Nle1 lies ~70
the location of each mutation. Stacked chromatographs show the sequenc
length, spliced mRNA product is shown with exons represented by empty
represented by a thin line on the mRNA transcript. F. NLE1 protein structure
domains; green diamonds: mutation sites.Animals carrying one copy of the balancer chromosome
have light ears and tails due to ectopic agouti expression
that reduces pigment [3,4,31,32]. The l11Jus1 line has
been continually maintained in our colony. The l11Jus4
line was resuscitated from cryopreserved spermatozoa of
an l11Jus4/In(11Trp53;11Wnt3)8Brd male with a C3H/
HeJ female (www.MMRRC.org, MMRRC:000074-UCD).
Pups were genotyped at weaning and l11Jus4/C3H/HeJ
males were backcrossed to In(11Trp53;11Wnt3)8Brd/Rex
females on a 129S6/SvEvTac genetic background. We
genotyped the progeny of both lines at least every 10
generations by microsatellite analysis or direct sequencing
of the mutations to ensure that we maintained the
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it is necessary to remove the balancer chromosome. Ani-
mals heterozygous for the l11Jus1 mutation (l11Jus1/In
(11Trp53;11Wnt3)8Brd) were mated to animals carrying
one copy of the inversion and the dominant curly coat
marker, Rex (In(11Trp53;11Wnt3)8Brd/Rex). We selected
animals with a curly coat (i.e. inherited the Rex allele) and
dark ears and tail (i.e. inherited the l11Jus1 mutation) for
meiotic mapping. We intercrossed F1 animals to generate
recombinant F2 animals, which were genotyped at several
microsatellite markers (D11Mit4, 219, 245, 120, 39, 327,
and 32) and single nucleotide variances (SNVs; Slc6a4,
Wsb1, Rad51l3 and Rasl10b) along the 34 Mb interval
(Figure 1B). Primers and PCR conditions are available
upon request.
For the Notch PCR array studies, qRT-PCR analysis and
caspase 3 detection, we outcrossed heterozygous males to
129S6/SvEvTac females (Taconic, Hudson, New York) to
eliminate genetic interactions with Wnt3. Heterozygotes,
which had dark ears and tails were mated, generating F2
blastocysts for analysis. Notch PCR array studies were
conducted on N5F2 embryos (Nle1
l11Jus1). qRT-PCR
studies were performed on N14F2 and N15F2 (Nle1
l11Jus1)
and N4F2 (Nle1
l11Jus4) embryos dissected at E3.5. Caspase
detection assays were carried out on N15F2 (Nle1
l11Jus1),
as well as N14F2 or N15F2 (Nle1
l11Jus4) embryos. All
mouse studies were conducted in facilities approved by the
American Association for the Accreditation of Laboratory
Animals with the approval of the Baylor College of
Medicine Animal Care and Use Committee or the Purdue
University Animal Care and Use Committee.
Embryo analysis
To determine time of death and perform phenotypic
studies, we examined embryos after timed matings, with
the day of the vaginal plug designated E0.5. We geno-
typed each one as described [3,4]. DNA was isolated by
incubating whole embryos (E6.5 to E9.5) in 1 X PCR
buffer (Life Technologies, Grand Island, NY) and 0.08
mg/ml Proteinase K (Life Technologies, Grand Island,
NY) at 55°C for 2–3 hours. Proteinase K was inactivated
by either heating to 95°C for 10 min or by phenol:
chloroform:Isoamyl alcohol extraction followed by etha-
nol precipitation. Alternatively, embryos were incubated
in 25 to 50 μl of 25 mM NaOH, 0.2 mM EDTA for 60
min at 95°C. Genomic DNA was neutralized by the
addition of an equal amount of 40 mM Tris–HCl, pH
8.0 and stored at −20°C. D11Mit327 was used to
genotype the embryos in a 25 μl PCR reaction under the
following conditions: 1 X PCR buffer, 1.5 mM MgCl2,
0.2 mM dNTPs, 250 pmoles of each primer and 0.625 U
of Taq Polymerase (Life Technologies, Grand Island,
NY). After an initial denaturing step at 95°C for 5 min,
D11Mit327 was amplified with the following cyclingparameters: 30 cycles of 94°C for 30 s, 60°C for 30 s
followed by 72°C for 30 s, with a final 5 min incubation
at 72°C. Products were size fractionated on 5% Metaphor
(Cambrex, Bio Science, Rockland, ME), 0.5 X TBE gels.
Histology
Deciduas were dissected at E6.5–E8.5. Implantation sites
were fixed for 3 hours in Bouin’s fixative, embedded in
paraffin, sectioned in 5–7 μm slices and stained in
hematoxylin and eosin as described [33]. Stained sections
were analyzed under light microscopy.
Candidate gene interrogation
Exons of candidate genes were bidirectionally sequenced
directly from PCR amplicons using the Big DyeW
Teminator v3.1 (Life Technologies, Grand Island, NY)
sequencing mix. Each amplicon contained at least one
exon, plus ≥ 200 bp of flanking sequence. For the
l11Jus1 mutation, genomic DNAs from 129S6/SvEvTac,
C57BL/6J and l11Jus1/In(11Trp53;11Wnt3)8Brd mice
were sequenced as controls. For the l11Jus4 mutation,
genomic DNAs from 129S6/SvEvTac, C57BL/6J, In
(11Trp53;11Wnt3)8Brd/C3H, and l11Jus4/C3H, and
l11Jus4/In(11Trp53;11Wnt3)8Brd mice were sequenced
as controls. Sequence data was analyzed (Sequencher;
Gene Codes, Ann Arbor, MI) to identify mutations on
the l11Jus1 and l11Jus4 alleles, as well as any additional
sequence variants.
Notch pathway expression of l11Jus1 mutants at E3.5
We analyzed Notch pathway gene expression in homozy-
gous mutant and homozygous wild-type blastocysts using
the SAB PCR Arrays (SABiosciences/Qiagen, Frederick,
MD). Embryos were washed in EmbryoMax© M2 media
(M2; EMD Milllipore, Billerica, MA) and transferred into
100 μl of RNAqueous lysis buffer (RNAqueous-Micro Kit,
Life Technologies, Grand Island, NY). After vortexing, we
snap-froze each tube in liquid nitrogen and stored each
sample at −80°. Total RNA was isolated following manufac-
turer’s instructions, eluting with 20 μl of nuclease-free
water. We used 5 μl of RNA to generate cDNA for
genotyping in a half reaction of SuperScript One-Step
RT-PCR with Platinum Taq (Life Technologies, Grand
Island, NY) with gene specific primers, oligo dT, and PCR
primers (Table 1). We used nested PCR for sequencing
(Figure 1E). We collected 45 mutant and 45 wild-type E3.5
embryos, and split embryos with the same genotype into 3
pools (i.e. biological replicates); each pool consisted of
morulae, half-blastocysts, full blastocysts and hatched
blastocysts. We then performed a linear amplification step
on each pool using the RT2 Nano PreAMP cDNA synthesis
kit (SABioscience, Frederick, MD). Each biological replicate
was subdivided into 3 technical replicates. Data from each
Table 1 Primers used for this study
Forward sequence Reverse sequence Tm Size
Nle1 sequencing primers
Nle1E1/2 CTTGACTCCTCCGAACACGAG AAACACAGCCTGTCTGTAGGTGAG 62 500
Nle1E3 GATTAAATTTGTCGCATGGTGGTA GTCTGTTACTTGCAACGTGAGTCC 62 475
Nle1E4 TATTTCTCCTCAGGGAATGGAGAG CCACACTCAGTCCAGTATCTGCTT 62 377
Nle1E5/6 CTGTGTTCTCCCTCACCTCTCC ATAGTAGGCCAAGCCGTTGCT 62 557
Nle1E7 ACAGCCTTGCTCTGCTGTTAGAA GGACCAGCTGGACTCTTGGTATAA 62 440
Nle1E8/9 TTCCTGATTCTTGCCTTATGTCAC AACCCTAACTAAGACAACCAAGAACAA 62 544
Nle1E10 TGGAGTTGCATGTAAGCTTGTGT GTCACTAGCCCTAAAGATGCCATT 62 488
Nle1E11/12 CCGGCCCAGGTACCTAGCTT ACCTACAGGTTCTCCCAGAGTCTCC 62 498
Nle1E13 ACTTGATACTTGGCAGTAGGCACA CTCCTGCTATCCAGTGCAAGG 62 570
Nle1 genotyping primers
Nle1 GSP GCTGTAATGTCCTGACTGT 60 637
cDNA 1 CTGTGTCGTACTCTTCAAGGTCAT CTGTGGAGTCATCTTCTCCATATC
cDNA 2 TCAGACGACTTCACCTTATTCCTG CAGTCAACAGCATATACCTCATCG 62 351
Nle1 DNA TCTCCTTCAGCTCCTTCACTGT TCCAATGGTGGAGTATAGGGTATAA 60 341
cDNA amplification primers
1st PCR ATATGGATCCGGCGCGCCGTCGACT24 ATATCTCGAGGGCGCGCCGGATCCT24 67
2nd PCR (NH2)ATATGGATCCGGCGCGCCGTCGACT24 (NH2)ATATCTCGAGGGCGCGCCGGATCCT24 67
Eed GTGTGACATTTGGTACATGAGGTT ACATTTATGATGGGTCAGTGTTGT 60 148
TaqMan gene expression assay
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detection system (Bio-Rad, Hercules, CA).
PCR array data analysis for gene expression
Cycle threshold (Ct) values were calculated for all data
obtained from 18 PCR plates. We calculated the optimal
threshold values based on the value for each plate by
selecting the auto calculate threshold position and the
PCR base-line subtracted analysis mode from the iCycler
Data Analysis Software (Bio-Rad, Hercules, CA). The
highest threshold position was 1415 PCR base-line sub-
tracted relative fluorescence units (RFU). We re-analyzed
each plate by entering 1415 as the user defined threshold
position. Therefore, we were able to compare replicates
across multiple plates using Ct values generated from the
common threshold position.
We used the SABiosciences RT2 Profiler Data
Analysis Software to determine gene expression profiles
(http://www.sabiosciences.com/pcr/arrayanalysis.php). This
software calculated fold regulation values for each gene
using the relative quantification 2-ΔΔCt method [34]. Each
plate met the quality assurance criteria listed by the
manufacturer for genomic DNA contamination, reversetranscription inhibition, and PCR cycling conditions. ΔCt
values were normalized using the mean values of three
housekeeping genes: Gusb, Hsp90ab1, and Actb. All wells
with a Ct value above 29.5 cycles were excluded from the
analysis. This left 65 transcripts for analysis.
Caspase 3 detection
Active caspase were detected based on a fluorescent
inhibitor of caspase (FLICA) approach [35,36]. Zona-free
embryos were placed on slides and incubated with FLICA
caspase 3 reagent (Image-iT™ LIVE Red caspase-3 and −7
Detection Kit, Life Technologies, Grand Island, NY) in M2
medium at 37°C for one hour. FLICA was removed and the
embryos were washed with M2 media, counterstained with
Hoechst dye for 3 minutes and washed with buffer pro-
vided by the manufacturer. Embryos were fixed in 1% PFA
for 10 min and mounted on cover slides. Each embryo
was imaged with Zeiss LSM510 microscope (20X object-
ive) and the images were pseudo-colored using Adobe
Photoshop (Adobe Systems, Inc., San Jose, CA). To geno-
type, we collected each embryo in 10 μl of 100 μg/ml Pro-
teinase K solution, incubated the embryos at 55°C for 10
minutes, and then heat inactivated at 95°C for 5 minutes.
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rounds of PCR using primers that flanked an insertion/de-
letion in exon 8.
Quantative RT-PCR (qRT-PCR) by TaqMan
RNA isolated from embryos separated by genotype (mutant
vs. wild-type) and stage (morula, full blastocyst and
hatched blastocyst) was reverse transcribed individually fol-
lowing the protocol by Tang and Colleagues [37]. Follow-
ing a 1:1 addition of 100% ethanol, RNA was concentrated
with a SpeedVac for 15 mins, resuspended in 4.5 μl lysis
buffer and reverse transcribed. We performed a two-step
linear amplification process using barcoded primers as
described [37]. Products from the first and second rounds
were purified using Zymo DNA concentration kits (Zymo
Research, Irvine, CA) and eluted in 30 μl of 1 X T10E0.1.
Eed expression was used to check the cDNA quality fol-
lowing the first linear amplification step (primers listed in
Table 1). cDNA was quantified using a Bio-Rad Smart-
Spec™ Plus Spectrophotometer. Ten ng of cDNA was used
as a template for qRT-PCR in combination with TaqManW
Gene Expression Master Mix (PN#4369514; Life Tech-
nologies, Grand Island, NY) and Taqman Gene-specific
probes (Life Technologies, Grand Island, NY) on a Prism
7000HT Sequence Detection System (Life Technologies,
Grand Island, NY). We assayed a minimum of three bio-
logical replicates for each group. Cycling reactions were
performed in duplicate or triplicate. The relative expression
of each gene was calculated based on the ΔΔCt value,
where the results were normalized to the average Ct value
of Gapdh. Samples that failed to generate a signal above
threshold at the end of the reaction were given a Ct value
of 40.
Statistical methods
SAB PCR Array Study. These data can be thought of as a
complex nested block design: Plate is nested within Pool
and Pool is nested within Genotype (Plate and Pool are
both blocks). Transcript is nested within biological Role
(each transcript was assigned one biological Role), and
transcript and role are crossed with each level of nesting
(i.e. each transcript is measured on each plate). The data
were analyzed in a GLM, blocked by Plate nested within
Pool, and Pool nested within Genotype. Transcript was
nested within Role; and Role and Transcript crossed
with the blocking factors Plate and Pool, and with the
experimental factor Genotype. Each Plate and Pool acted
as its own control. The relationship of Plates as technical
replicates from the same Pools is recognized. Transcript
describes the overall expression profile, while Role
describes the overall Functional Profile, and their inter-
actions with Genotype test (respectively) whether
particular Transcripts differ from the average for the
Role between Genotypes, and whether particular Rolesdiffer as a whole between Genotypes. We partitioned
out between-plate error and used this as the error term
for analyses for two reasons: 1) the plate reader software
controls within plate error and 2) the use of between-
plate error is conceptually equivalent to (the source of
error in a traditional ANOVA approach testing each
gene independently. By using ΔCt values, the analysis
directly calculates ΔΔCt.
qRT-PCR study by TaqMan analysis. We adopted a
similar GLM approach to individually test and calculate
the ΔΔCt values from Cdkn1a and Trp53 gene expres-
sion studies. Since we used the –ΔCt for each individual
as raw data, genotype interactions figures and tests a
ΔΔCt value. We also tested for common changes in gene
expression in different stages of pre-implantation deve-
lopment and used the full pairwise comparisons table to
generate the individual ΔΔCt values and standard errors.
Results
Phenotypic analysis of l11Jus1 and l11Jus4
We screened a cohort of 59 lethal mutants (45 of which
were embryonic lethal) that were generated by ENU
mutagenesis [3], and identified an allelic series of two
mutants (l11Jus1 and l11Jus4) mapping to mouse
chromosome 11 that failed to gastrulate. Histological
sections performed at embryonic day (E) 7.5 show com-
pletely resorbing implantation sites compared to control
littermates (Figure 2). In contrast, animals inheriting two
copies of the 34 Mb inversion, In(11Trp53;11Wnt3)8Brd,
are homozygous mutant for Wnt3 and display a distinct,
much less severe phenotype during the gastrulation
stage (Table 2) [3,4]. Complementation studies revealed
that the phenotype of the l11Jus1/l11Jus4 double hetero-
zygotes is identical to either single homozygous mutant
(data not shown), thereby placing l11Jus1 and l11Jus4 in
the same complementation group.
Penetrance of l11Jus1 (L1) (Table 2A): We genotyped a
total of 34 l11Jus1 (L1/L1) homozygotes (32 normal and
2 abnormal blastocysts), 117 heterozygotes (L1/Inv) and
49 animals homozygous for the inversion (Inv/Inv). We
failed to genotype 98 embryos due to lack of DNA from
normal (n = 40) and abnormal (n = 2) embryos;
resorption sites (n = 38) and lost embryos (n = 18)
accounted for the remainder of non-genotyped embryos.
At E6.5, we detected 0 homozygous mutant embryos out
of 62 total embryos. X2 analysis indicates that these
numbers are statistically significant, with p < 0.0001
(Table 3). At the blastocyst stage (E3.5), we detected
normal Mendelian ratios, indicating that the time of
death occurs between E3.5 and E6.5.
Penetrance of l11Jus4 (L4) (Table 2B). We genotyped a
total of 28 l11Jus4 (L4/L4) homozygotes (all normal),
153 heterozygotes (L4/Inv) and 49 animals homozygous





Figure 2 Mutant Phenotypes. H&E stained sections at E7.5 A. Wild type implantation site B. l11Jus1 implantation site. C. l11Jus4 implantation
site. embryo (Em), extra-embryonic region (Ex), and maternal decidua (D).
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abnormal (n = 2) embryos; resorption sites (n = 46) and lost
embryos (n = 1) accounted for the remainder of non-
genotyped embryos. At E6.5, we detected 0 homozygous
mutant embryos out of 32 total embryos. X2 analysis indi-
cates that these numbers are statistically significant, with a
p-value of 0.004 (Table 3). At the blastocyst stage (E3.5), we
detected all genotypes, but saw an unexpectedly high
number of heterozygotes (p = 0.014). Together, these data
indicate that l11Jus1 homozygotes and l11Jus4 homozy-
gotes both die in utero prior to E6.5.
Positional cloning of l11Jus1 and l11Jus4
Since L1 and L4 homozygotes failed at the implantation
stage, meiotic mapping would be difficult, at best, usingTable 2 Time of death for Nle1 mutants
A. Time of death for l11Jus1 Mutants
Abnormal
Day Resorbed No DNA L1/L1 L1/Inv Inv/Inv
3.5 0 2 2 4 3
6.5 28 0 0 0 18
7.5 3 0 0 0 1
8.5 3 0 0 2 3
9.5 4 0 0 1 1
Total 38 2 2 7 26
B. Time of death for l11Jus4 Mutants
Abnormal
Day Resorbed No DNA L4/L4 L4/Inv Inv/Inv
3.5 0 2 0 8 3
6.5 16 0 0 4 9
7.5 7 0 0 0 4
8.5 13 0 0 5 5
9.5 10 0 0 0 1
Total 46 2 0 17 22traditional methods that rely on haplotype analysis in
phenotypically mutant animals. To circumvent this
obstacle, we narrowed the critical interval by exclusion
mapping (Figure 1A). Exclusion mapping involves haplo-
type analysis of all progeny at weaning for several
markers across the candidate interval (i.e. from Trp53 to
Wnt3 on Mmu 11). Since homozygous mutants are
embryonic lethal, any marker that is homozygous for the
mutant allele (i.e. C57BL/6J) will effectively ‘exclude’ this
marker from the candidate interval. Parents were hetero-
zygous for the l11Jus1 mutation and for the dominant
coat color marker, Rex. Throughout the 34 Mb critical
interval, l11Jus1 is on a C57BL/6J background, while Rex
is on a 129S6/SvEvTac background. Since the balancer
chromosome is not present in the F1 generation, it isNormal
No DNA L1/L1 L1/Inv Inv/Inv Lost Total
40 32 58 23 1 165
0 0 42 0 10 98
0 0 5 0 3 12
0 0 1 0 4 13
0 0 4 0 0 10
40 32 110 23 18 298
Normal
No DNA L4/L4 L4/Inv Inv/Inv Lost Total
6 28 86 27 1 161
0 0 19 0 0 48
0 0 19 0 0 30
0 0 11 0 0 34
3 0 1 0 0 15
9 28 136 27 1 288
Table 3 X2 Analysis of selected timed matings
Genotype Observed Expected Stage Total embryos P value
l11Jus1/l11Jus1 34 50 All 200 0.018
l11Jus1/In(11Trp53;11Wnt3)8Brd 117 100
In(11Trp53;11Wnt3)8Brd/In(11Trp53;11Wnt3)8Brd 49 50
l11Jus1/l11Jus1 34 30.5 E3.5 122 0.582
l11Jus1/In(11Trp53;11Wnt3)8Brd 62 61
In(11Trp53;11Wnt3)8Brd/In(11Trp53;11Wnt3)8Brd 26 30.5
l11Jus1/l11Jus1 0 15 E6.5 60 3.71703E-05
l11Jus1/In(11Trp53;11Wnt3)8Brd 42 30
In(11Trp53;11Wnt3)8Brd/In(11Trp53;11Wnt3)8Brd 18 15
l11Jus4/l11Jus4 28 57.5 All 230 5.17678E-07
l11Jus4/In(11Trp53;11Wnt3)8Brd 153 115
In(11Trp53;11Wnt3)8Brd/In(11Trp53;11Wnt3)8Brd 49 57.5
l11Jus4/l11Jus4 28 38 E3.5 152 0.014
l11Jus4/In(11Trp53;11Wnt3)8Brd 94 76
In(11Trp53;11Wnt3)8Brd/In(11Trp53;11Wnt3)8Brd 30 38
l11Jus4/l11Jus4 0 8 E6.5 32 0.004
l11Jus4/In(11Trp53;11Wnt3)8Brd 23 16
In(11Trp53;11Wnt3)8Brd/In(11Trp53;11Wnt3)8Brd 9 8
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events on one or both parental alleles. These recom-
bination events were visualized by haplotype analysis in
the F2 generation (Figure 1B). We genotyped 487
progeny (974 individual meiotic events), and narrowed
the critical region to a 4.4 Mb domain flanked by Wsb1
and D11Mit120 (Figure 1B, C).
Of the 75 genes in this interval, 16 top candidates
were selected based on microarray expression data and
mutant phenotype. We sequenced 8 of these genes in
the process of identifying the l11Jus1 and l11Jus4
mutations: adaptor-related protein complex 2, beta1 sub-
unit (Ap2b1); chaperonin containing Tcp1, subunit 6b
(zeta) (Cct6b); suppressor of zest 12 homolog (Suz12);
fringe isoform 1 (Rffl); ecotropic viral integration site 2a
(Evi2a); proteasome (prosome, macropain) 26S subunit
non-ATPase 11 (Psmd11); TAF15 RNA polymerase II,
TATA box binding protein (TBP)-associated factor
(Taf15); and Notchless homolog 1 (Drosophila) (Nle1).
We found no non-synonymous mutations in our first 7
candidates (Ap2b1, Cct6b, Suz12, Rffl, Evi2a, Psmd11 or
Taf15) [38]. However, we identified a T 1184 G transver-
sion (I 395 S missense mutation) in l11Jus1 heterozygotes
in exon 10 of Nle1 (Figure 1D). This non-conservative
substitution replaces an aliphatic, hydrophobic amino acid
with a polar residue, which likely disrupts functionality
[39]. Subsequent mutation detection efforts resulted in
the identification of a second missense mutation (T 484 C
transition; S 162 P missense mutation) in exon 5 of Nle1
for the l11Jus4 allele (Figure 1D). This non-conservativeamino acid substitution has a high probability to alter
protein function, as serines easily form hydrogen bonds
with polar substrates, while prolines are rarely found in
active sites [39]. In addition, we detected an endogenous
C57BL/6J non-synonymous SNV (A 535 G transition;
I 179 V) in exon 6 (Figure 1D). This well-documented
SNV (rs2820949) leads to a very conservative amino acid
substitution [39]. Both mutants share the endogenous mu-
tation (Figure 1D, 1F), indicating that l11Jus1 and l11Jus4
homozygotes harbor two coding changes in Nle1–an
ENU-induced allele and an endogenous C57BL/6J mis-
sense mutation.
Sequence variations within the Nle1 locus
We identified 21 new polymorphisms and compiled a
list of all of the polymorphisms found to date within the
Nle1 locus (MGI dbSNP Build 128) (Additional file 1:
Table S1) [40]. Nle1 is transcribed from the Crick strand,
and variances are ordered in reference to Nle1, not the
chromosome. The nucleotide position is noted in
column one (NCBI Build 37) and the location within
Nle1 in column two. Variances detected within exons
are designated as synonymous (S) or non-synonymous
(N). Variances reported in the MGI database, but not
found in our sequencing studies are depicted by gray
cells, and dbSNP IDs for previously identified changes
are noted.
We included known variants in the reference strain
(C57BL/6J), as well as those found in the 129S1/SvImJ,
C3H/HeJ, NOD and CzechII strains, and the strains that
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and C3HeB/FeJ). In total, there are 73 variances across the
Nle1 locus, including 5’ and 3’ UTR sequences. We saw no
discordance between the C57BL/6J sequences and the
reference sequence. We discovered 10 new indels;
129S6/SvEvTac and C3HeB/FeJ had identical sequences
across these regions, while C57BL/6J, l11Jus1 and
l11Jus4 segregated together. cDNA comparison studies
also indicate that the NOD allele (Genbank Accession #
AK170853.1) has a single nucleotide deletion in the
3’UTR sequence [41]. All polymorphisms identified in the
129S6/SvEvTac and C3HeB/FeJ strains are new. We iden-
tified five new expressed SNVs across the gene and one
expressed indel in the 3’UTR. One previously reported
expressed SNV (rs28209059) is a missense mutation
(C 912 G; Additional file 1; Table S1) in the 129S1/SvImJ
and C3J/HeJ strains. This results in a neutral amino acid
substitution (N 291 K) [39] within exon 8, which does not
encode for any type of functional domain.
The Nle1 locus
BLAT analysis of the mouse RefSeq cDNA (Accession #
NM_15431) at the UCSC genome browser [42], reveals that
the Nle1 locus contains 13 exons and spans 7628 bp of ge-
nomic DNA. cDNA and EST sequences indicate the poten-
tial for generating several alternatively-spliced transcripts.
The RefSeq cDNA is predicted to encode a 485 amino acid
protein that has an NLE1 domain at the N-terminus and 8
WD40-like repeats (Figure 1F). NLE1 is highly conserved,
with orthologues in multiple species, even yeast and plants;
it is over 91% identical among mouse, rat, human and cow
(Figure 3). In addition, it is highly conserved in yeast (42%),
fruit fly (55%) and potato (58%) (data not shown).
Expression analysis of the Notch pathway in mutant
embryos
Since Nle1l11Jus1/l11Jus1 embryos die shortly after implan-
tation, while disruption of NOTCH signaling by multiple
methods (i.e. targeted deletion of Notch receptors and
ligands, [11-21], γ-secretase [27] or Pofut1 [25,26]) in mice
leads to embryonic lethality after mid-gestation, we
hypothesized that Nle1l11Jus1/l11Jus1 and Nle1l11Ju41/l11Jus4
mutants had defects in multiple signaling pathways. To
test for defects in NOTCH signaling, we analyzed Notch
pathway gene expression in homozygous mutant
(i.e. Nle1l11Jus1/l11Jus1) blastocysts using the PAMM-059
Notch Pathway SAB PCR Array (SABiosciences/Qiagen,
Frederick, MD). We compared expression levels of 84
Notch pathway genes in Nle1l11Jus1/l11Jus1 pre-implantation
embryos to Nle+/+ control littermates.
We eliminated 19 genes, including 8 Notch downstream
targets (Cflar, Ifng, Il2ra, Pparγ, Cd44, Dtx1, Krt1 and
Ptcra) and the Notch ligand, Dll1, due to lack of expression
(i.e. had a Ct value ≥ 29.5). This left 65 genes for statisticalanalysis, including the Notch receptors (Notch1-4), Jagged
ligands (Jag1-2) and receptor processing and modifying
enzymes (i.e. the γ-secretase complex and protein
O-fucosyltransferase genes: Adam10, Adam17, Psen1,
Psen2, Psenen and Pofut1).
Notch target genes include Cdkn1a (a marker of cell
cycle arrest), Hes1, Hey1, Stat6, Nr4a2, Nfkb1 and Pparg
(transcriptional regulators), Ccnd1 (cell cycle), as well as
Chuk, Il17b and Krt1 (downstream targets with unspe-
cified functions in the NOTCH pathway). In addition,
the PCR array contains several members of the Wnt
(Aes, Axin1, Lrp5, Fzd1-7 and Wnt11) and Hedgehog
signaling pathways (Gli1, Gsk3b, Shh, Smo and Sufu). To
ensure biological significance, genes with less than a 1.5
fold change were included in the statistical analyses, but
not considered differentially expressed.
We analyzed the data using a GLM blocked by plate
(technical replicate) nested within pool (biological repli-
cate) and pool nested within genotype. Transcript levels
were nested within biological function/pathway (role).
Role and transcript were crossed with the blocking factors
plate and pool, and with the experimental factor
genotype. Therefore, testing for genotype X transcript
interactions will identify single genes that are statistically
upregulated or downregulated in mutant embryos, while
testing for genotype X role interactions identifies groups
of genes with similar biological functions (i.e. Wnt
pathway, transcriptional regulation, etc.) that are as a
whole misregulated in mutant embryos compared to
wild-type controls. The role (GLM: F7,84 = 248.3;
P < 0.0001) and transcript (F7,84 = 224.0; P < 0.0001)
effects were significant, indicating the presence of
consistent functional and expression profiles in both
genotypes.
The genotype X transcript interaction was significant
(F57,684 = 1.5490; P = 0.0073), indicating that at least one
transcript differed from the overall mean of transcripts
within the same role. Of the 16 Notch target genes
detected in this study, 6 were overexpressed by at least
1.5 fold (Cdkn1a, Nfkb1, Hes1, Erbb2 (Esr2), Il17b,
Map2k7). However only Cdkn1a, which was upregulated
by 4.7 fold in mutant samples (Figure 4) (p = 1.94X10-8),
was statistically significant using post hoc tests corrected
for multiple comparisons (accepting p < 0.000769); none
of the other genes approached significance, even at an
uncorrected threshold of p < 0.05.
Seven genes demonstrated a more than 1.5 fold reduc-
tion in expression in Nle1l11Jus1/l11Jus1 embryos: Lrp5,
Fzd7, Fzd4 and Wnt11, which are members of the Wnt
signaling pathway, and Chuk, Nr4a2 and Stat6. However,
none of these met the rigorous criteria (p < 0.000769)
that accounts for the multiple comparison analysis.
Setting aside Bonferroni corrections for false positive
detection rate, and accepting a false discovery rate (FDR)
L1              --MAAAVVEEAAAGDVQRLLVQFQDEGGQLLGSPFDVPVDITPDKLQLVCNALLAQEEPL 58
L4              --MAAAVVEEAAAGDVQRLLVQFQDEGGQLLGSPFDVPVDITPDKLQLVCNALLAQEEPL 58
C57BL/6         --MAAAVVEEAAAGDVQRLLVQFQDEGGQLLGSPFDVPVDITPDKLQLVCNALLAQEEPL 58
Mouse          --MAAAVVEEAAAGDVQRLLVQFQDEGGQLLGSPFDVPVDITPDKLQLVCNALLAQEEPL 58
CZECHII         --MAAAVVEEAAAGDVQRLLVQFQDEGGQLLGSPFDVPVDITPDKLQLVCNALLAQEEPL 58
Rat             MAAAVEVSDEAAASDVQRLLVQFQDEGGQLLGSPFDVPVDITPDQLQLVCNALLAQDEPL 60
Human           --MAAAVPDEAVARDVQRLLVQFQDEGGQLLGSPFDVPVDITPDRLQLVCNALLAQEDPL 58
Cow             -MAAAAAADEAATRDVQRLLVQFQDEGGQLLGSPFDVPVDITPDKLQLVCNALLAQEDPL 59
*. . :**.: ******************************:***********::**
L1              PLAFYVHDAEIVSSLGKTLESQSVETEKIVDIIYQPQAVFRVRAVTRCTSSLEGHSEAVI 118
L4              PLAFYVHDAEIVSSLGKTLESQSVETEKIVDIIYQPQAVFRVRAVTRCTSSLEGHSEAVI 118
C57BL/6         PLAFYVHDAEIVSSLGKTLESQSVETEKIVDIIYQPQAVFRVRAVTRCTSSLEGHSEAVI 118
Mouse           PLAFYVHDAEIVSSLGKTLESQSVETEKIVDIIYQPQAVFRVRAVTRCTSSLEGHSEAVI 118
CZECHII         PLAFYVHDAEIVSSLGKTLESQSVETEKIVDIIYQPQAVFRVRAVTRCTSSLEGHSEAVI 118
Rat             PLAFYVHDAEIVSSLGKTLESQSVETEKIVDIIYQPQAVFRVRAVTRCTSSLEGHSEAVI 120
Human           PLAFFVHDAEIVSSLGKTLESQAVETEKVLDIIYQPQAIFRVRAVTRCTSSLEGHSEAVI 118
Cow             PLAFYVHDAEIVSSLGRTLESQAVETEKVLDIIYQPQAIFRVRAVTRCTSSLEGHSEAVI 119
****:***********:*****:*****::********:*********************
L1              SVAFSPTGKYLASGSGDTTVRFWDLSTETPHFTCKGHRHWVLSISWSPDGKKLASGCKNG 178
L4              SVAFSPTGKYLASGSGDTTVRFWDLSTETPHFTCKGHRHWVLSIPWSPDGKKLASGCKNG 178
C57BL/6         SVAFSPTGKYLASGSGDTTVRFWDLSTETPHFTCKGHRHWVLSISWSPDGKKLASGCKNG 178
Mouse           SVAFSPTGKYLASGSGDTTVRFWDLSTETPHFTCKGHRHWVLSISWSPDGKKLASGCKNG 178
CZECHII         SVAFSPTGKYLASGSGDTTVRFWDLSTETPHFTCKGHRHWVLSISWSPDGKKLASGCKNG 178
Rat             SVAFSPTGKYLASGSGDTTVRFWDLSTETPHFTCKGHRHWVLSISWSPDGKKLASGCKNG 180
Human           SVAFSPTGKYLASGSGDTTVRFWDLSTETPHFTCKGHRHWVLSISWSPDGRKLASGCKNG 178
Cow             SVAFSPTGKYLASGSGDTTVRFWDLSTETPHFTCQGHRHWVLSISWSPDGKKLASGCKNG 179
**********************************:*********.*****:*********
L1              QVLLWDPSTGLQVGRTLTGHSKWITGLSWEPLHMNPECRYVASSSKDGSVRVWDTTAGRC 238
L4              QVLLWDPSTGLQVGRTLTGHSKWITGLSWEPLHMNPECRYVASSSKDGSVRVWDTTAGRC 238
C57BL/6         QVLLWDPSTGLQVGRTLTGHSKWITGLSWEPLHMNPECRYVASSSKDGSVRVWDTTAGRC 238
Mouse           QILLWDPSTGLQVGRTLTGHSKWITGLSWEPLHMNPECRYVASSSKDGSVRVWDTTAGRC 238
CZECHII         QILLWDPSTGLQVGRTLTGHSKWITGLSWEPLHMNPECRYVASSSKDGSVRVWDTTAGRC 238
Rat             QILLWDPSTGTQVGRTLTGHSKWITGLSWEPLHMNPECRYVASSSKDGSVRVWDTTAGRC 240
Human           QILLWDPSTGKQVGRTLAGHSKWITGLSWEPLHANPECRYVASSSKDGSVRIWDTTAGRC 238
Cow             QILLWDPSTGKQVGRALTGHSKWITALSWEPLHANPECRYVASSSKDGSVRVWDTTAGRC 239
*:******** ****:*:*******.******* *****************:********
L1              ERILTGHTQSVTCLRWGGDGLLYSASQDRTIKVWRAHDGVLCRTLQGHGHWVNTMALSTD 298
L4              ERILTGHTQSVTCLRWGGDGLLYSASQDRTIKVWRAHDGVLCRTLQGHGHWVNTMALSTD 298
C57BL/6         ERILTGHTQSVTCLRWGGDGLLYSASQDRTIKVWRAHDGVLCRTLQGHGHWVNTMALSTD 298
Mouse           ERILTGHTQSVTCLRWGGDGLLYSASQDRTIKVWRAHDGVLCRTLQGHGHWVNTMALSTD 298
CZECHII         ERILTGHTQSVTCLRWGGDGLLYSASQDRTIKVWRAHDGVLCRTLQGHGHWVNTMALSTD 298
Rat             ERILTGHTQSVTCLRWGGDGLLYSASQDRTIKVWRAHDGVLCRTLQGHGHWVNTMALSTD 300
Human           ERILTGHTQSVTCLRWGGDGLLYSASQDRTIKVWRAHDGVLCRTLQGHGHWVNTMALSTD 298
Cow             ERTLTGHAQSVTCLRWGGDGLLYSASQDRTIKVWRAHDGVLCRTLQGHGHWVNTMALSTD 299
** ****:****************************************************
L1              YALRTGAFEPAEATVNAQDLQGSLKELKERASSRYNLVRGQGPERLVSGSDDFTLFLWSP 358
L4              YALRTGAFEPAEATVNAQDLQGSLKELKERASSRYNLVRGQGPERLVSGSDDFTLFLWSP 358
C57BL/6         YALRTGAFEPAEATVNAQDLQGSLKELKERASSRYNLVRGQGPERLVSGSDDFTLFLWSP 358
Mouse           YALRTGAFEPAEATVNAQDLQGSLKELKERASSRYNLVRGQGPERLVSGSDDFTLFLWSP 358
CZECHII         YALRTGAFEPAEATVNAQDLQGSLKELKERASSRYNLVRGQGPERLVSGSDDFTLFLWSP 358
Rat             YALRTGAFEPAEATVNAQDLQGSLKELKERASSRYNLVRGQGPERLVSGSDDFTLFLWSP 360
Human           YALRTGAFEPAEASVNPQDLQGSLQELKERALSRYNLVRGQGPERLVSGSDDFTLFLWSP 358
Cow             YALRTGAFEPAEASVNAQDLRGSLQELKERALSRYNLVRGQGPERLVSGSDDFTLFLWSP 359
*************:**.***:***:****** ****************************
L1              AEDKKPLARMTGHQALINQVLFSPDSRIVASASFDKSVKLWDGRTGKYLASLRGHVAAVY 418
L4              AEDKKPLARMTGHQALINQVLFSPDSRIVASASFDKSIKLWDGRTGKYLASLRGHVAAVY 418
C57BL/6         AEDKKPLARMTGHQALINQVLFSPDSRIVASASFDKSIKLWDGRTGKYLASLRGHVAAVY 418
Mouse           AEDKKPLARMTGHQALINQVLFSPDSRIVASASFDKSIKLWDGRTGKYLASLRGHVAAVY 418
CZECHII         AEDKKPLARMTGHQALINQVLFSPDSRIVASASFDKSIKLWDGRTGKYLASLRGHVAAVY 418
Rat             AEDKKPLARMTGHQALINQVLFSPDSRIVASASFDKSIKLWDGRTGKYLASLRGHVAAVY 420
Human           AEDKKPLTRMTGHQALINQVLFSPDSRIVASASFDKSIKLWDGRTGKYLASLRGHVAAVY 418
Cow             AEDKKPLARMTGHQALINQVVFSPDSRVIASASFDKSIKLWDGRTGKYLASLRGHVAAVY 419
*******:************:******::********:**********************
L1              QIAWSADSRLLVSGSSDSTLKVWDVKAQKLATDLPGHADEVYAVDWSPDGQRVASGGKDK 478
L4              QIAWSADSRLLVSGSSDSTLKVWDVKAQKLATDLPGHADEVYAVDWSPDGQRVASGGKDK 478
C57BL/6         QIAWSADSRLLVSGSSDSTLKVWDVKAQKLATDLPGHADEVYAVDWSPDGQRVASGGKDK 478
Mouse           QIAWSADSRLLVSGSSDSTLKVWDVKAQKLATDLPGHADEVYAVDWSPDGQRVASGGKDK 478
CZECHII         QIAWSADSRLLVSGSSDSTLKVWDVKAQKLATDLPGHADEVYAVDWSPDGQRVASGGKDK 478
Rat             QIAWSADSRLLVSGSSDSTLKVWDVKAQKLTTDLPGHADEVYAVDWSPDGQRVASGGKDK 480
Human           QIAWSADSRLLVSGSSDSTLKVWDVKAQKLAMDLPGHADEVYAVDWSPDGQRVASGGKDK 478
Cow             QIAWSADSRLLVSGSSDSTLKVWDVKAQKLSTDLPGHADEVYAVDWSPDGQRVASGGKDK 479
******************************: ****************************
L1              CLRIWRR 485
L4              CLRIWRR 485
C57BL/6         CLRIWRR 485
Mouse           CLRIWRR 485
CZECHII         CLRIWRR 485
Rat             CLRIWRR 487
Human           CLRIWRR 485
Cow             CLRIWRR 486
*******
Figure 3 NLE1 protein sequence alignment. NLE1 is highly conserved among mouse, rat, cow and human.


























































































































Figure 4 (See legend on next page.)
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Figure 4 Expression of Nle1l11Jus1 embryos using a Notch-specific PCR array. Each transcript is listed (left), with fold change indicated (top).
The mean expression level for each transcript is indicated. The least-squares mean ΔΔCT ± SE is shown for each transcript, with equivalent fold-
change. The dashed line indicates that Cdkn1a is the only gene with significant differences in expression following a Bonferonni correction for
multiple comparisons. The dotted line represents transcripts where p < 0.05. Biological roles were taken directly from the SAB website.
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http://www.biomedcentral.com/1471-2156/13/106of 5% leads to the inclusion of Fzd7 (p = 0.00168),
Nr4a2 (p = 0.00422), Fzd4 (p = 0.00461) and Chuk
(p = 0.02492); using an FDR of 10% leads to the inclu-
sion of Wnt11 (p = 0.02679) (Figure 4). This analysis
indicates that multiple members of the Wnt pathway are
downregulated in Nle1 mutant embryos.Confirmation of Cdkn1a in different stages of
pre-implantation development
The SAB PCR array study was performed on three pools
(n = 15) of E3.5 embryos at different stages (i.e. a mix of
morula, blastocysts and hatched blastocysts). This could
have introduced biased expression or masked subtle
alterations in stage-specific gene expression due to pool-
ing of embryos from different stages. To control for
these possibilities and confirm the PCR array results, we
analyzed expression of Cdkn1a between wild-type and
mutant embryos at multiple embryonic stages (morula,
full blastocyst and hatched blastocyst) in single embryos
using TaqMan assays. Expression of each gene was nor-
malized relative to expression of Gapdh and compared
to the stage-matched wild-type controls. Wild-type
expression was set at a value of one.
We used a multivariate GLM model to calculate ΔΔCt
and fold change and to properly control and test for dif-
ferences between the mutant alleles and stages of deve-
lopment. Using a least squares mean, which corrected
for all of the variables in the analysis (line, genotype,
stage of development), we did not detect differences in
Cdkn1a expression between mutants compared to con-
trol embryos as a function of stage (morula, blastocyst
and hatched blastocyst; F2,32 = 0.2701; P = 0.7650), line
(Nle1l11Jus1 and Nle1l11Jus4; F1,32 = 1.293; P = 0.2640) or
stage and line (F2,32 = 0.0574; P = 0.9444), indicating
that we did not detect differences in expression due to
developmental stage or mutant line. However, overall,
Cdkn1a was expressed at 4.69 fold (95% CI: 1.02 - 21.5
fold) higher levels both in Nle1l11Jus1/l11Jus1 and
Nle1l11Jus4/l11Jus4 mutant embryos compared to wild-type
controls at all stages (GLM: F1,32 = 4.2561; P = 0.0473).
These data are consistent with our PCR array findings
for l11Jus1 mutant embryos, show that there are no
significant differences in expression of Cdkn1a at the
different stages tested in the PCR array, and demonstrate
that the phenotypes associated with l11Jus1 and l11Jus4
do not differ at the molecular level.Apoptosis occurs at E4.5 in Nle1l11Jus1/l11Jus1 and
Nle1l11Jus4/l11Jus4 mutants
These Cdkn1a expression findings are intriguing, as
targeted disruption of Nle1 in mice indicated that mutant
embryos started to undergo apoptosis at E3.5 plus 1 day in
culture, which is approximately equivalent to E4.5 embryos
(i.e. hatched blastocysts) [30]. If our mutant embryos were
also undergoing apoptosis, we would expect that they
would not show high levels of Cdkn1a, as Cdkn1a expres-
sion is most often an indication that cells have exited the
cell cycle following a DNA damage response or other type
of cellular stress event [43,44]. However the function of
CDKN1A in cell cycle arrest and apoptosis is still unclear,
as other studies have shown that Cdkn1a expression levels
can be upregulated in cells undergoing apoptosis [45].
Given that Cdkn1a was expressed at much higher levels in
Nle1 mutants compared to wild-type embryos, we
hypothesized that animals expressing high levels of Cdkn1a
would be protected from apoptosis at E3.5, but would ul-
timately become apoptotic by E4.5, which would be con-
sistent with previous studies [30].
Therefore, we analyzed caspase 3 activity at E3.5 and
E4.5 (Figure 5; Table 4). We tested these data in a single
logistic multiple regression. We detected caspase 3 activity
solely in homozygous mutants (Likelihood Ratio χ2 = 21.75,
p < 0.0001) at E4.5 (LR χ2 = 15.11; p < 0.0001). Strain had
no effect (LR χ2 < 0.0001; p > 0.9999). We did not find
any evidence for an interaction between genotype and
stage (LR χ2 < 0.0001; p > 0.9999). Overall, these data
indicate that apoptosis appears at E4.5, but not at E3.5,
that apoptosis is only seen in homozygous mutants and
that these two effects are independent and additive in
both alleles.qRT-PCR analysis of Trp53 in mutant embryos
We then asked whether the apoptotic phenotype is
Trp53-dependent. Taqman assays were conducted to
compare Trp53 expression between wild-type and mutant
embryos. Identical GLM models were used to calculate
fold change and test significance, with additional planned
contrasts performed to test differences at different embry-
onic stages. Trp53 expression did not differ between
control and mutant embryos overall (GLM: F1,33 = 0.5316;
P = 0.4711), by line (F1,33 = 0.0057; P = 0.9404), by em-
bryonic stage (F2,33 = 0.0994; P = 0.9056), or the inter-







Figure 5 Caspase 3 detection in Nle1l11Jus1 mutant embryos. caspase 3 detection in mutant and wild type embryos at E3.5 (200X) and E4.5
(200X). Positive caspase 3 staining is only detected in E4.5 mutants. Red staining indicates the presence of caspase 3 signal and blue is Hoechst
staining. White arrows point out caspase staining. Merged images are shown.
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http://www.biomedcentral.com/1471-2156/13/106Together, the gene expression and caspase 3 data indi-
cate that Nle1l11Jus1/l11Jus1 and Nle1l11Jus4/l11Jus4 homozy-
gotes undergo caspase 3-mediated apoptosis at the
hatched blastocyst stage. This is not mediated by altera-
tions in mRNA levels of Trp53, and apoptosis does not
correlate with upregulation of Cdkn1a expression in
homozygous mutant embryos, as upregulation of Cdnk1a
occurs from the morula through the hatched blastocyst
stage, even though apoptosis only is observed at the latest
stages. Furthermore, we demonstrate that several mem-
bers of the Wnt pathway are downregulated in mutant
embryos, suggesting that NLE1 interacts with the WNT
pathway during pre-implantation development.Table 4 Logistic multiple regression analysis of caspase 3
detection
Genotype/stage 129/129 Mutant/129 Mutant/Mutant Total
caspase 3 + – + – + –
l11Jus1 E3.5 morula/
blastocyst
0 1 0 5 0 2 8
l11Jus1 E4.5 hatched
blastocyst
0 2 0 5 2 0 9
l11Jus4 E3.5 morula/
blastocyst
0 4 0 5 0 3 12
l11Jus4 E4.5 hatched
blastocyst
0 3 0 4 3 0 10Discussion
We present evidence that the l11Jus1 and l11Jus4 mu-
tant phenotypes are caused by non-conservative mis-
sense mutations in the Nle1 gene. Gene targeting studies
indicate that l11Jus1 and l11Jus4 phenocopy the null al-
lele [5]. These ENU mutants were created on a C57BL/
6J background, which also contains a conservative mis-
sense mutation in Nle1. Therefore, l11Jus1 and l11Jus4
homozygotes harbor two mutations within predicted
functional domains of NLE1. Previous studies in Dros-
ophila and Xenopus indicate that NLE1 is a member of
the NOTCH pathway [5,6]. NOTCH signaling facilitates
short-range cell-cell communication during diverse cel-
lular processes, in multiple tissues and at a multitude of
developmental stages. Loss of function or gain of func-
tion mutations in various factors that are fundamental to
canonical NOTCH signaling are often associated with
developmental disorders, adult-onset diseases and a var-
iety of cancers in humans [22].
However, the function of NLE1 in NOTCH signaling
remains elusive. Initial studies in Drosophila show that
NLE1 function is context and dosage dependent. NLE1
was identified as a dominant suppressor of the viable
mutant allele, notchoid [6]. Notchoid mutants have char-
acteristic wing notches; in the notchoid mutant back-
ground, Nle1 heterozygosity (i.e. Nle1/+) rescued the
notchoid phenotype, while simultaneously causing
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overexpression of wingless, the Drosophila Wnt ortholo-
gue, in the notchoid background also rescues the notch-
oid phenotype [46,47], while overexpression of Notch
leads to shortened, thickened wing veins [48]. Since
NLE1 can bind the NOTCH intracellular domain
(NICD), these experiments suggest that NLE1 is a nega-
tive regulator of NOTCH, and that NLE1 functions by
blocking the ability of the NICD to regulate expression
of downstream targets. Studies in Xenopus come to the
opposite conclusion, as overexpression of Murine [5] or
a combination of Xenopus and Drosophila [6] Nle1
mRNAs into single blastomeres at the 4-cell or 2-cell
stage, respectively, lead to decreased numbers of primary
neurons at the early neurula stage. These results indicate
that NOTCH activity was upregulated following injec-
tion of Nle1 mRNAs, suggesting that NLE1 positively
regulates NOTCH signaling.
These studies indicate that NLE1 acts as both a positive
and negative regulator of NOTCH signaling. If NLE1 acts
as a general positive regulator of NOTCH signaling during
murine pre-implantation development, then elimination of
NLE1 could lead to compensatory over-expression of the
Notch receptors, ligands and protease family members, but
reduced expression of downstream target genes. In con-
trast, if NLE1 functions as a negative regulator of NOTCH
signaling, we would predict that disruption of NLE1 would
lead to increased expression of Notch target genes. To our
surprise, we saw no generalized misregulation of Notch
target genes in the PCR array study. In addition, the Notch
receptors, ligands and other family members were not
significantly altered. At a false discovery rate of 5%, the only
genes that are misregulated in the PCR array study were:
Cdkn1a, Nr4a2, Fzd7, Fzd4 and Chuk. Cdkn1a, Nr4a2 and
Chuk are downstream targets of NOTCH signaling, while
Fzd7 and Fzd4 encode receptors in the WNT pathway. To
tease out the gene expression changes that occurred during
specific pre-implantation stages, we analyzed expression of
Cdkn1a on individual staged embryos (morulae, full blasto-
cysts and hatched blastocysts). Cdkn1a was significantly
upregulated in Nle1l11Jus1/l11Jus1 and Nle1l11Jus4/l11Jus4
animals at all three stages. These studies indicate that
mutations in Nle1 do not significantly affect the NOTCH
pathway during pre-implantation development.
CDKN1A is a powerful cyclin-dependent kinase inhibitor
that functions in several developmental pathways and nega-
tively regulates the cell cycle at G1 via a TRP53-mediated
response to DNA damage [49]. This can happen directly by
competing with DNA polymerase δ for PCNA binding sites
at the replication fork, leading to decreased DNA synthesis
[50]. Alternatively, CDKN1A can inhibit CDK2, which
leads to suppression of E2F-dependent transcripts, down-
regulation of components of the DNA synthesis machi-
nery and reduced firing at origins of replication [51]. Inaddition, CDKN1A can act as a negative regulator of
caspase-mediated apoptosis [49]. Gene targeting studies
demonstrated that the inner cell mass of Nle1−/− embryos
was undergoing apoptosis via a caspase-dependent me-
chanism in E3.5 blastocysts that were cultured for 24
hours [5]. We analyzed caspase 3 activity in blastocysts
and hatched blastocysts at E3.5 and E4.5. Consistent with
the results of Cormier and colleagues (2006), we demon-
strate that l11Jus1 and l11Jus4 show evidence of apoptosis
only in hatched blastocysts.
Although we show upregulation of Cdkn1a and down-
regulation of several members of the Wnt pathway, how
these two networks work together to regulate pre-
implantation development is still unknown. One attractive
possibility is via the TRP53-mediated stress response
pathway, which is upstream of CDKN1A. We predicted
that if our Nle1 mutations were causing severe cellular
damage, the cell would not be able to recover during cell
cycle arrest (at E3.5), which would then force the cell to
undergo apoptosis (at E4.5). If this were true, we would
expect to see increased expression of Trp53, as the cells
proceeded through apoptosis. However, we did not detect
altered expression of Trp53 by qRT-PCR studies in our
mutants at any stage. In retrospect, this result is not that
surprising, as TRP53-mediated apoptosis (via Cdkn1a
upregulation) is not necessarily correlated with mRNA ex-
pression of Trp53, but is instead associated with upregula-
tion of the active, acetylated form of the TRP53 protein
[52]. Alternately, it is possible that the expression changes
in Trp53 were too subtle to detect, or apoptosis could be
occurring via non-TRP53 mediated pathways [53].
Conclusions
Our results refute the possibility that NLE1 functions as
a negative regulator of NOTCH signaling during mam-
malian pre-implantation development, as mutation of
Nle1 does not lead to increased expression of key Notch
downstream target genes. In addition, our PCR array
studies indicate that most downstream targets of
NOTCH are unaffected by Nle1 mutations. Much to our
surprise, instead of confirming the role of NLE1 in the
NOTCH pathway, our data implicate NLE1 in WNT sig-
naling and cell cycle arrest and/or apoptosis via Cdkn1a
during pre-implantation development. Although NOTCH
signaling is dispensable in mice prior to gastrulation, WNT
signaling is not. Deletion of Wnt3 leads to failure prior to
primitive streak formation [54], and multiple Wnt ligands
and Fzd receptors are detected at the blastocyst stage
[55,56], as well as in the uterus during peri-implantation
[57-59]. We provide evidence that NLE1 is co-opted by the
WNTand CDKN1A pathways in mammals, while in lower
vertebrates, several studies indicate that NLE1 acts in the
NOTCH pathway, and reports in yeast and plants (which
lack NOTCH signaling) demonstrate a role for NLE1 in
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form widely varied functions in a species and stage-
dependent context, and out studies suggest that NLE1 may
co-opt different signaling pathways during different stages
of development.
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